Grantham, Mayo, Van Otterloo & Co (GMO)
CAH icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Cardinal Health CAH Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,784
Closed -$377K – 673
2026
Q1 		$377K Sell
1,784
-1,159
-39% -$250K ﹤0.01% 571
2025
Q4 		$605K Buy
2,943
+1,410
+92% +$265K ﹤0.01% 568
2025
Q3 		$241K Sell
1,533
-18,001
-92% -$2.78M ﹤0.01% 576
2025
Q2 		$3.28M Buy
+19,534
New +$2.9M 0.01% 338
2022
Q1 		– Sell
-157,500
Closed -$8.11M – 700
2021
Q4 		$8.11M Sell
157,500
-38,300
-20% -$1.88M 0.04% 284
2021
Q3 		$9.68M Buy
195,800
+137,816
+238% +$7.48M 0.05% 252
2021
Q2 		$3.31M Buy
57,984
+9,244
+19% +$540K 0.02% 392
2021
Q1 		$2.96M Buy
48,740
+32,100
+193% +$1.77M 0.02% 415
2020
Q4 		$891K Buy
16,640
+5,400
+48% +$280K 0.01% 582
2020
Q3 		$528K Buy
+11,240
New +$577K ﹤0.01% 618
2016
Q2 		– Sell
-4,800
Closed -$393K – 574
2016
Q1 		$393K Buy
+4,800
New +$390K ﹤0.01% 482
2015
Q2 		– Sell
-2,400
Closed -$217K – 445
2015
Q1 		$217K Buy
+2,400
New +$207K ﹤0.01% 425
2014
Q2 		– Sell
-56,000
Closed -$3.92M – 505
2014
Q1 		$3.92M Sell
56,000
-41,397
-43% -$2.88M 0.01% 330
2013
Q4 		$6.51M Sell
97,397
-329,266
-77% -$20.1M 0.02% 263
2013
Q3 		$22.3M Sell
426,663
-168,858
-28% -$8.58M 0.06% 133
2013
Q2 		$28.1M Buy
+595,521
New +$27.2M 0.07% 106

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s CAH Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 1,784 shares — an estimated $377K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CAH in Q2 2013 and held it in 16 quarters. The position peaked at $28.1M in Q2 2013. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,784 Cardinal Health shares in Q2 2026, an estimated $377K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Cardinal Health in Q2 2013 and held it in 16 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Cardinal Health position peaked at $28.1M in Q2 2013.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.